November 30, 2021

EAVE II study on risk of COVID-19 hospitalisations among school-aged children with poorly-controlled asthma

The EAVE II (Early Pandemic Evaluation and Enhanced Surveillance of COVID-19) project has been tracking the COVID-19 pandemic in near real-time in Scotland.

A new study from the team looks at the risk of COVID-19 hospitalisations among school-aged children (aged 5-17 years) with asthma.  This has been published in the Lancet Respiratory Medicine.

Journalists dialled in to this briefing to ask any questions and to hear the scientists behind the study discuss aspects such as:

– were children with asthma more likely to be hospitalised with COVID-19?

– did risk of COVID-19 hospitalisation vary depending on whether the asthma was mild or poorly controlled?

– how many children in the UK are affected by asthma of different severities?

– what are the implications of the findings of the study?

Speakers included:

Prof Aziz Sheikh, Director of the Usher Institute, and Professor of Primary Care Research & Development, University of Edinburgh; and EAVE II study lead

Prof Chris Robertson, Professor of Public Health Epidemiology, University of Strathclyde

Dr Ting Shi, Chancellor’s Fellow, Deanery of Molecular, Genetic and Population Health Sciences, Usher Institute, University of Edinburgh

This Briefing was accompanied by an SMC Roundup of Comments.